142 related articles for article (PubMed ID: 1493939)
1. Granulocyte-macrophage colony-stimulating factor (GM-CSF): a variety of possible applications in clinical medicine.
Weiss M; Belohradsky BH
Infection; 1992; 20 Suppl 2():S81-3. PubMed ID: 1493939
[No Abstract] [Full Text] [Related]
2. [GM-CSF and G-CSF: cytokines in clinical application].
Ruef C; Coleman DL
Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
[TBL] [Abstract][Full Text] [Related]
3. [Report on the current indications for colony stimulating factors (G-CSF and GM-CSF)].
Med Clin (Barc); 1994 May; 102(19):747-50. PubMed ID: 7518884
[No Abstract] [Full Text] [Related]
4. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
[TBL] [Abstract][Full Text] [Related]
5. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
6. Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant.
Goa KL; Bryson HM
Pharmacoeconomics; 1994 Jan; 5(1):56-77. PubMed ID: 10146867
[TBL] [Abstract][Full Text] [Related]
7. [Hematopoietic growth factor (GM-CSF) after autologous bone marrow transplantation. A randomized, double-blind, multicenter study in 91 cases of non-Hodgkin's malignant lymphomas].
Gorin NC; Coiffier B; Hayat M; Fouillard L; Kuentz M; Flesch M; Colombat P; Boivin P; Slavin S; Lemarié JC
Presse Med; 1993 Jan; 22(3):109-20. PubMed ID: 8493215
[TBL] [Abstract][Full Text] [Related]
8. [Emergency therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF)].
Gratwohl A; Dazzi H; Tichelli A; Stebler C; Wernli M; Thomssen C; Kim I; Dieterle A; Obrist R; Stern A
Schweiz Med Wochenschr; 1991 Mar; 121(12):413-7. PubMed ID: 2028244
[TBL] [Abstract][Full Text] [Related]
9. Southwestern Internal Medicine Conference: clinical use of hematopoietic growth factors.
Fleischman RA
Am J Med Sci; 1993 Apr; 305(4):248-73. PubMed ID: 7682752
[TBL] [Abstract][Full Text] [Related]
10. The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications.
Hill AD; Naama HA; Calvano SE; Daly JM
J Leukoc Biol; 1995 Dec; 58(6):634-42. PubMed ID: 7499960
[TBL] [Abstract][Full Text] [Related]
11. A review of the efficacy and tolerability of recombinant haematopoietic growth factors in bone marrow transplantation.
Barge AJ
Bone Marrow Transplant; 1993; 11 Suppl 2():1-11. PubMed ID: 8334433
[TBL] [Abstract][Full Text] [Related]
12. Emerging clinical uses for GM-CSF.
Scarffe JH
Eur J Cancer; 1991; 27(11):1493-504. PubMed ID: 1835868
[No Abstract] [Full Text] [Related]
13. Clinical applications of human granulocyte-macrophage colony-stimulating factor.
Sakamoto KM; Gasson JC
Int J Cell Cloning; 1991 Nov; 9(6):531-41. PubMed ID: 1770227
[TBL] [Abstract][Full Text] [Related]
14. Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level.
Vadhan-Raj S; Broxmeyer HE; Hittelman WN; Papadopoulos NE; Chawla SP; Fenoglio C; Cooper S; Buescher ES; Frenck RW; Holian A
J Clin Oncol; 1992 Aug; 10(8):1266-77. PubMed ID: 1634916
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma.
Advani R; Chao NJ; Horning SJ; Blume KG; Ahn DK; Lamborn KR; Fleming NC; Bonnem EM; Greenberg PL
Ann Intern Med; 1992 Feb; 116(3):183-9. PubMed ID: 1345803
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-macrophage colony-stimulating factor given before dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP).
Holdsworth MT; Roon R; Ferguson J; Martinez L; Stidley CA; Neidhart JA
Biotechnol Ther; 1993; 4(3-4):183-95. PubMed ID: 8292969
[TBL] [Abstract][Full Text] [Related]
17. Pharmacoeconomic issues in the use of granulocyte-macrophage colony-stimulating factor for bone marrow transplantation or chemotherapy-induced neutropenia.
Weber RJ
Clin Ther; 1993; 15(1):180-91; discussion 168. PubMed ID: 8458047
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte macrophage-colony stimulating factor (GM-CSF) in neonatal neutropenia.
Ray M; Mukhopadhyay K; Narang A
Indian J Pediatr; 2000 Jan; 67(1):67-8. PubMed ID: 10832225
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-macrophage colony stimulating factor (rh-GM-CSF) in the treatment of chemotherapy-induced neutropenia.
Gözdasoglu S; Unal E; Yavuz G; Pamir A; Reisli I; Deda G; Tarcan A; Babacan E; Cavdar AO
J Chemother; 1995 Oct; 7(5):467-9. PubMed ID: 8596135
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial.
Ravaud A; Chevreau C; Cany L; Houyau P; Dohollou N; Roché H; Soubeyran P; Bonichon F; Mihura J; Eghbali H; Tabah I; Bui BN
J Clin Oncol; 1998 Sep; 16(9):2930-6. PubMed ID: 9738560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
